A Cluster-Randomized Trial of Blood-Pressure Reduction in Black Barbershops

Autor: Ciantel A. Blyler, Robert Elashoff, Norma B Moy, Davontae Foxx-Drew, Kathleen Lynch, Mohamad Rashid, Ning Li, Anthony E. Reid, Eric Muhammad, Jeffrey W. Brettler, Brent Hsu, Ronald G. Victor, Joel F. Handler
Rok vydání: 2018
Předmět:
Male
medicine.medical_specialty
Clinical Trials and Supportive Activities
education
Psychological intervention
Pharmacist
Blood Pressure
Health Promotion
030204 cardiovascular system & hematology
Pharmacists
Cardiovascular
Barbering
Medical and Health Sciences
law.invention
Cohort Studies
03 medical and health sciences
0302 clinical medicine
Drug Therapy
Randomized controlled trial
Clinical Research
law
General & Internal Medicine
Health care
medicine
Humans
030212 general & internal medicine
Cluster randomised controlled trial
Life Style
Antihypertensive Agents
health care economics and organizations
African Americans
business.industry
Prevention
General Medicine
Middle Aged
Health Services
Black or African American
Good Health and Well Being
Blood pressure
Socioeconomic Factors
Hypertension
Combination
Cohort
Physical therapy
Drug Therapy
Combination

Self Report
business
Cohort study
Zdroj: The New England journal of medicine, vol 378, iss 14
ISSN: 1533-4406
0028-4793
DOI: 10.1056/nejmoa1717250
Popis: BackgroundUncontrolled hypertension is a major problem among non-Hispanic black men, who are underrepresented in pharmacist intervention trials in traditional health care settings.MethodsWe enrolled a cohort of 319 black male patrons with systolic blood pressure of 140 mm Hg or more from 52 black-owned barbershops (nontraditional health care setting) in a cluster-randomized trial in which barbershops were assigned to a pharmacist-led intervention (in which barbers encouraged meetings in barbershops with specialty-trained pharmacists who prescribed drug therapy under a collaborative practice agreement with the participants’ doctors) or to an active control approach (in which barbers encouraged lifestyle modification and doctor appointments). The primary outcome was reduction in systolic blood pressure at 6 months.ResultsAt baseline, the mean systolic blood pressure was 152.8 mm Hg in the intervention group and 154.6 mm Hg in the control group. At 6 months, the mean systolic blood pressure fell by 27.0 mm Hg (to 125.8 mm Hg) in the intervention group and by 9.3 mm Hg (to 145.4 mm Hg) in the control group; the mean reduction was 21.6 mm Hg greater with the intervention (95% confidence interval, 14.7 to 28.4; P
Databáze: OpenAIRE